ESC 365 - Clinical value of anti-fibrotic strategies.

HFA Premium Access

Clinical value of anti-fibrotic strategies.

Session: Anti-fibrotic therapies in heart failure.

Topic: Cardiac Diseases

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

108 presentations

8 followers

3 more presentations in this session

Myocardial fibrosis: new concepts.

Speaker: Professor S. Heymans (Maastricht, NL)

Targeting the cellular origin of cardiac fibrosis.

Speaker: Professor J. Hulot (Paris, FR)

Natural compounds to treat cardiac fibrosis.

Speaker: Professor T. Thum (Hannover, DE)

Access the full session

Anti-fibrotic therapies in heart failure.

Speakers: Professor F. Zannad, Professor S. Heymans, Professor J. Hulot, Professor T. Thum

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources